Market Report, "Vietnam Pharmaceuticals & Healthcare Report Q4 2012", Published
BMI View: Growth in pharmaceutical sales in Vietnam will be driven by increasing affluence, an increasingly ageing population and the country's high burden of both communicable and noncommunicable diseases, therefore the country's prospects will continue to attract pharmaceutical firms. However, a downside risk for non-domestic firms is the country's resistance to foreign direct investments.
View full press release